Managing the Hospitalized Patient with Opioid Use Disorder · 2019. 11. 15. · Walley AY,...
Transcript of Managing the Hospitalized Patient with Opioid Use Disorder · 2019. 11. 15. · Walley AY,...
ManagingtheHospitalizedPatientwithOpioidUseDisorder
MARLENEMARTINASSISTANTCLINICALPROFESSOR
UNIVERSITYOFCALIFORNIA,SANFRANCISCO
23RDANNUALMANAGEMENTOFTHEHOSPITALIZEDPATIENTCMECOURSEOCTOBER18,2019
35Ymanadmittedovernightwithrightupperextremityerythema,pain,andswelling
● Startedonempirictreatmentforcellulitis● Youaregettingsignoutfromyourovernightcolleaguewhenyougetpaged
thatheiscomplainingofdiarrhea,abdominalpain,headache,andnausea● Youevaluatethepatientandnoteheisyawningandthathispupilsare
dilated.Heendorseslastusingheroinbeforebeingadmitted
Objectives 1. Diagnoseandtreatopioidwithdrawalandopioid
usedisorder(OUD)witheithermethadoneorbuprenorphine
2. Identifyhowtolinkhospitalizedpatientstobuprenorphineormethadonetreatmentondischarge
3. NamethreeoptionsforOUDharmreduction
Outline q Prevalence,demographics,andcharacteristicsofhospitalizedpatientswithOUD
q DiagnosingOUDq Medicationtreatment
q Cases
Source: CDC, 2017
ThreeWavesofOpioidOverdoseDeaths
Source: AHRQ, 2017
OUD-relatedhospitalizationsandEDvisitsalmostdoubledinthelastdecade
SUDamonghospitalizedpatientso Upto25%ofhospitalizedpatientso Morelikelytobeadmittedfromtheemergencydepartment
o Longerlengthsofstay,costlier,higherreadmission
o HighAMArates
o Lowestquartileofincome
o Unconnectedtocare
StatisticalBrief#249.HealthcareCostandUtilizationProject(HCUP).March2019.AgencyforHealthcareResearchandQuality,Rockville,MD.BrownRL,LeonardT,SaundersLAetal.Theprevalenceanddetectionofsubstanceusedisordersamonginpatientsages18to49:anopportunityforprevention.PrevMed1998;27(1):101-10).EnglanderH,WeimerM,SolotaroffRetal.PlanningandDesigningtheImprovingAddictionCareTeam(IMPACT)forHospitalizedAdultswithSubstanceUseDisorder.JHospMed.2017May;12(5):339-342.Spooner,K.K.,Salemi,J.L.,Salihu,H.M.,Zoorob,R.J.,2017.DischargeagainstmedicaladviceintheUnitedStates,2002-2011.MayoClin.Proc.92,525–535.WalleyAY,Paasche-OrlowM,LeeEC,etal.Acutecarehospitalutilizationamongmedicalinpatientsdischargedwithasubstanceusedisorderdiagnosis.JAddictMed.2012Mar;6(1):50-6.RonanMVandHerzigSJ.HospitalizationsRelatedToOpioidAbuse/DependenceAndAssociatedSeriousInfectionsIncreasedSharply,2002-12.HealthAff(Millwood).2016May1;35(5):832-7.
WhytreatOUDinthehospital?o Eliminatewithdrawalandreducecravingso Ifreturntousewhileontreatmentoccurs,less/nohigh
o Maintaintolerance
o RootcauseofEDvisits,admissions,andreadmissions
o Patientsmotivatedtocutbackorstopuse–pivotaltouchpoint
o Whenaddressed:o ImprovedratesofPCPandaddictiontreatmentfollowupo Reducedsubstanceuseafterdischargeo Lower30-dayreadmissionso Improvedpatientandproviderexperiences
VelezCM,NicolaidisC,KorthuisPT,EnglanderH."It'sbeenanExperience,aLifeLearningExperience":AQualitativeStudyofHospitalizedPatientswithSubstanceUseDisorders.JGenInternMed.2017Mar;32(3):296-303.WeiJ,DefriesT,LozadaM,YoungN,HuenW,TulskyJ.Aninpatienttreatmentanddischargeplanningprotocolforalcoholdependence:efficacyinreducing30-dayreadmissionsandemergencydepartmentvisits.JGenInternMed.2015Mar;30(3):365-70.EnglanderH,CollinsD,PerrySPetal."We'veLearnedIt'saMedicalIllness,NotaMoralChoice":QualitativeStudyoftheEffectsofaMulticomponentAddictionInterventiononHospitalProviders'AttitudesandExperiences.JHospMed.2018Nov1;13(11):752-758.EnglanderH,WeimerM,SolotaroffRetal.PlanningandDesigningtheImprovingAddictionCareTeam(IMPACT)forHospitlaizedAdultswithSubstanceUseDisorder.JHospMed.2017May;12(5):339-342.LiebschutzJM,CrooksD,HermanD.Buprenorphinetreatmentforhospitalized,opioid-dependentpatients:arandomizedclinicaltrial.JAMAInternMed.2014Aug;174(8):1369-76.
Outline q Prevalence,demographics,andcharacteristicsofhospitalizedpatientswithOUD
q DiagnosingOUDq Medicationtreatment
q Cases
Symptoms◦ Withdrawal◦ Uncontrolledpain
Diagnoses◦ Skinandsofttissueinfections◦ Endocarditis,osteomyelitis◦ Trauma◦ Overdose
DSMCriteria◦ Chronicpain
NotallwhouseopioidshaveOUD
DiagnosingOUD
Riskofbodilyharm
Withdrawal
Tolerance
Control:Exceededownlimits
Failedattemptstoquit/controluse
Compulsion:Timeusing,getting,recovering
Gaveupothermeaningfulactivities
Consequences:Relationshiptrouble
Physical/psychologicalconsequences
Rolefailure
Craving
ImpairedControl
SocialImpairment
RiskyUse
PharmacologicalCriteria
Outline q Prevalence,demographics,andcharacteristicsofhospitalizedpatientswithOUD
q DiagnosingOUDq Medicationtreatment
q Cases
Opioids: full agonist heroin, oxycodone, fentanyl, etc
Methadone: full agonist Activates receptor
Buprenorphine: partial agonist High affinity, ceiling effect
Extended-release naltrexone, naloxone: Full antagonist, high affinity
Y
Y
Y
Y
ßMu receptor
MedicationsforOUD
MedicationsforOUDMethadone Buprenorphine
Treatmentretention Higherthanbuprenorphine Retentionimprovesatdoses>16mg
Officevisits Dailyvisitstotreatmentprogram Daily-monthly;canalsoprovideasDOTinsomesettings
Whocanprescribeinacutecare?
Anyinpatientproviderduringhospitalization.AnyproviderinED:upto72hoursdosing
Anyinpatientproviderduringhospitalization.AnyproviderinED:upto72hoursdosing
Whocanprescribeatdischarge?
OpiateTreatmentProgram(methadoneclinic) AnyproviderwithDATA2000Xwaiver
Sedation Yesathighdoses,non-tolerantpatientsorslowmetabolizers
Ceilingeffectforrespiratorydepression
Withdrawalwhenstarting Takestimetoreachcomfortabledose Needtobeinwithdrawal
Buprenorphine:precipitatedwithdrawal
o Mustbeinwithdrawalpriortoinduction
o Highaffinity Y Y Heroin
J L
Buprenorphine
0.
10.
20.
30.
40.
Inmethadone Outofmethadone Inbuprenorphine Outofbuprenorphine
Allcausemortalityper1000personyears
Source: Sordo et al, BMJ, 2017
DecreasedMortality
7264
127
0
20
40
60
80
Daysinbupover6months
%Patients
Maintenance Detox
Num
ber o
f Days
80
70
60
50
40
30
20
10
0
Source: Liebschutz et al, JAMA Internal Medicine, 2014
HospitalInitiationofBuprenorphine
%
%
Source:ChutuapeMetal,TheAmericanJournalofDrugandAlcoholAbuse,2001.
DetoxDoesn’tLast
Outline q Prevalence,demographics,andcharacteristicsofhospitalizedpatientswithOUD
q DiagnosingOUDq Medicationtreatment
q Cases
Opioid Use Disorder (OUD), Opioid Withdrawal, and Linkage to Treatment Da
y1
MethadoneGuideforOUDTreatmentandWithdrawal
q Utox,pregnancytest,considerQTc,CURES,COWS,confirmOUD
q Give20mgmethadoneq Every4hours->COWS,ifhavingcravingsorwithdrawal,give10mgmore.Donotexceed40mg
Day2
q GivetotalDay1doseinamq Every4hours->COWS,ifhavingcravingsorwithdrawal,give10mgmore.Donotexceed50mg
3 q GivetotalDay2doseinamandfollow
sameprotocol.Donotexceed60mg
Day4
q GiveDay3maxdose.Continueprotocoluntilreaching60mgdaily.Thenholdfor5daysbeforeincreasingby10mgevery5days
Day1
BuprenorphineGuideforOUDTreatmentand*Uncomplicated
Withdrawalq Utox,pregnancytest,CURES,COWS,confirmOUD,considerQTc&LFTs
q Startbuprenorphine(bup)whenmildwithdrawal(COWS>8)ornoopioidsfor5days.Ifreceivedopioids:q Shortactingàwait12hrsq Longactingàwait24-48hrsq Methadoneinlast5daysàrequesthelp
q Give**bup4-8mg(ensuresublingual)q 1hourlateràrecheckCOWS.If≥8give4mgmore
q 6hourslater(soonerifwithdrawing)àrecheckCOWS.If≥8give4mg.Maxdose16mgonDay1
Day2
q GivetotalDay1doseinam.TIDdosingifpatienthaspain
q 1hourlateràifhavingcravings,pain,orwithdrawalincreasetotaldailydoseby4-8mg
q Goaldailydose16-24mg/day.Ifgreater,requesthelp
Adjunctive Support Clonidine 0.1-0.3 mg PO q6-8 hours PRN
(NTE 1.2 mg/day) à Sweating, restlessness, hot flashes, watery eyes, anxiety
Loperamide 4 mg PO x 1, then 2 mg PRN (NTE 16 mg/24 hours) à Loose stools
Zofran 4 mg PO q 6 hours PRN à Nausea Trazodone or Melatonin à Insomnia Diphenhydramine 25-50 mg, PO q 8 hours
PRN à Insomnia or anxiety Tylenol and/or Ibuprofen 650 mg PO q 6
hours PRN à Pain
Bup and Methadone Quick Facts • Inpatient providers can order bup or methadone for OUD, opioid withdrawal, or to continue outpatient tx
• X-waivered providers can prescribe bup on discharge
• Inpatient providers cannot prescribe methadone for OUD on discharge *Uncomplicated = no methadone for 5
days, no acute pain or surgery, not altered, no severe illness
**If concerned for precipitated withdrawal, start with 2mg
Case145-year-oldmanwithahistoryofinjectionheroinuseisadmittedwithcellulitisofhisrightupperextremity.Twohoursafteradmission,hefeelsachyandnauseous.Hispulseis102,heissweating,andmovingfrequentlyinbed.Assumehissepsisisadequatelyaddressed,andhissymptomsarefromopioidwithdrawal.● Whatmedicationswouldyouofferhim?● Howwouldyoudecidewhentostartthesemedications?● Howwouldyoudosethesemedications?● WhatdoyoudowithhisOUDmedicationsatdischarge?
q COWS≥8,Mustbeinwithdrawalpriortoinduction
q Initialdose8-12haftershortacting,24-48hpostlongacting
q Transitioningfrommethadone—askforhelp
Buprenorphine
WithdrawalAssessmentCOWSshortcut:SubjectivesymptomsANDatleast1objectivewithdrawalsign• Subjective:Nausea,abdominalpain,myalgias,chills
• Objective(atleast1):Restlessness,sweating,rhinorrhea,dilatedpupils,wateryeyes,tachycardia,yawning,goosebumps,vomiting,diarrhea,tremor
WhenCOWS≥8,give4-8mg
Maxday1:16mg
Maxday2:24mg
Therapeuticdose16-24mg/day
Increasedose:craving,withdrawal,pain
Decreasedose:insomnia/mania,sedation
Precipitatedwithdrawal:morebuprenorphineORshortactingfullagonist
Buprenorphine
Monitoron60mgdailyfor5daysbeforeincreasingagainby5-10mg,thenholdthatdosefor5days,etc
Targetdailydose80-120mg
Day1
Startwith10-30mg,reassessin3-4hrs,mayadd10mgPRNw/dsx,max40mg
DocumentCOWS,sedationscores@0min,4h.GoalCOWS<5
Day2
TotalDay1+5-10mgPRN,max50mg
Day3
TodayDay2+5-10mgPRN,max60mg
Methadone
Daysatsteadydose
Peak 3-4
hours
Half life: 24-36 hours
Steady state: 3-7 days
Risk of overdose with induction
Methadone
Startmedicationintheacutesettingandcommunicatewith
PCPorOTP!
MethadoneCannotprescribeondischargeforOUD
OpioidTreatmentProgramPartnerwithlocalmethadone
clinic
BuprenorphinePrescribeatd/cifwaiveredandbridgetooutpatientplan
Telemedicine BridgeClinic
PrimaryCare(SAMHSAwebsitelistswaiveredproviders)OTP
(Somecarrybup)
MedicationCareTransition
Case260-year-oldwomanwithahistoryoftricuspidvalveendocarditisandanxietyisadmittedforacuteencephalopathy.Urinetoxicologyshowsmorphine,alprazolam,andcocaine.Shortlyafteradmission,shewakesupsweating,tremulous,agitated,andvomitingandisaskingtoleave.Assumehersymptomsarefromopioidwithdrawal.● Whatmedicationswouldyouofferforherwithdrawalifshedoes
notwanttocontinueOUDtreatmentafterdischarge?● Whatharmreductionmeasureswouldyouprovideifsheis
interestedintreatingtheOUDbutnotstoppingbenzosorcocaine?● Whatbloodworkcouldyouobtaintolookforcomplicationsof
OUD?
Opioid Use Disorder (OUD), Opioid Withdrawal, and Linkage to Treatment Da
y1
MethadoneGuideforOUDTreatmentandWithdrawal
q Utox,pregnancytest,considerQTc,CURES,COWS,confirmOUD
q Give20mgmethadoneq Every4hours->COWS,ifhavingcravingsorwithdrawal,give10mgmore.Donotexceed40mg
Day2
q GivetotalDay1doseinamq Every4hours->COWS,ifhavingcravingsorwithdrawal,give10mgmore.Donotexceed50mg
3 q GivetotalDay2doseinamandfollow
sameprotocol.Donotexceed60mg
Day4
q GiveDay3maxdose.Continueprotocoluntilreaching60mgdaily.Thenholdfor5daysbeforeincreasingby10mgevery5days
Day1
BuprenorphineGuideforOUDTreatmentand*Uncomplicated
Withdrawalq Utox,pregnancytest,CURES,COWS,confirmOUD,considerQTc&LFTs
q Startbuprenorphine(bup)whenmildwithdrawal(COWS>8)ornoopioidsfor5days.Ifreceivedopioids:q Shortactingàwait12hrsq Longactingàwait24-48hrsq Methadoneinlast5daysàrequesthelp
q Give**bup4-8mg(ensuresublingual)q 1hourlateràrecheckCOWS.If≥8give4mgmore
q 6hourslater(soonerifwithdrawing)àrecheckCOWS.If≥8give4mg.Maxdose16mgonDay1
Day2
q GivetotalDay1doseinam.TIDdosingifpatienthaspain
q 1hourlateràifhavingcravings,pain,orwithdrawalincreasetotaldailydoseby4-8mg
q Goaldailydose16-24mg/day.Ifgreater,requesthelp
Adjunctive Support Clonidine 0.1-0.3 mg PO q6-8 hours PRN
(NTE 1.2 mg/day) à Sweating, restlessness, hot flashes, watery eyes, anxiety
Loperamide 4 mg PO x 1, then 2 mg PRN (NTE 16 mg/24 hours) à Loose stools
Zofran 4 mg PO q 6 hours PRN à Nausea Trazodone or Melatonin à Insomnia Diphenhydramine 25-50 mg, PO q 8 hours
PRN à Insomnia or anxiety Tylenol and/or Ibuprofen 650 mg PO q 6
hours PRN à Pain
Bup and Methadone Quick Facts • Inpatient providers can order bup or methadone for OUD, opioid withdrawal, or to continue outpatient tx
• X-waivered providers can prescribe bup on discharge
• Inpatient providers cannot prescribe methadone for OUD on discharge *Uncomplicated = no methadone for 5
days, no acute pain or surgery, not altered, no severe illness
**If concerned for precipitated withdrawal, start with 2mg
HarmReduction Buprenorphineormethadone
Needleexchangeprograms
Reviewinjectionpractices Supervisedinjectionfacilities Buddysystem
HCVandHIVeducation,screening,andtreatment
HAV,HBV,&TDaPvaccinesprn Naloxone
StopOverdoseDeaths Universalnaloxoneprescribing
◦ OUD◦ Opioids◦ Anydruguse
Bupren
orph
ine
PostDischargeLinkage
q PrimaryCareifPCPisXwaivered.Ifnot,check*SAMHSAtofindbupprovider.Giveenoughbuptobridgetoappointment.Communicated/cplanwithPCP.
q SUDBridgeClinicifavailableq SomeOTPshaveDOTforbupq Telemedicineq Emergencyadministration(ieinED)forupto72hours
q Someavailableformulations:q Bup-naloxoneSLfilmsq Bup-naloxoneSLtabsq Buprenorphinetabs
Metha
done
q OTP(methadoneclinic)->refertooneinyourcommunity.Establishpartnershipstoeasetransitions.Greatforpatientswhoneedmorestructure.
HarmReductionChecklistq HIVandHCVtestingandtreatmentq HAV,HBV,&TDaPvaccinesprnq Reviewsafeinjectionpractices
q Don'tusealoneq Cleaninjectionsiteq Injectslowlyorusetestshotq Usecleanneedleandothersupplies("works")
q Don'tshareneedlesorworksq Needleexchangeprogramsq Bupormethadoneasharmreductionq Naloxoneforeverypatientq PrEP/PEPq Treatwithdrawalevenifpatientisambivalentormaynotwantbupormethadoneafterdischarge
Other Resources • UCSF Substance Use Warmline: Call
855-300-3595, weekdays PST 6 am-5 pm for Addiction MD, RN, or pharmacist
• ED-Bridge: Detailed resources at: https://ed-bridge.org • SAMHSA: Find waivered providers at: https://www.samhsa.gov
Withdrawal Assessment COWS shortcut: Subjective symptoms AND at least 1 objective withdrawal sign • Subjective: Nausea, abdominal pain,
myalgias, chills, runny nose • Objective (at least 1): Restlessness,
sweating, rhinorrhea, dilated pupils, watery eyes, tachycardia, yawning, goose bumps, vomiting, diarrhea, tremor
Diagnosing OUD 1. Does the patient use heroin and have
signs and symptoms of withdrawal? If YES -> OUD.
2. If unsure OR no signs of withdrawal OR patient using prescription drugs, refer to DSM criteria below
DSMCriteria
Riskofbodilyharm ExceedsownlimitsRolefailure RelationshiptroubleUnabletocutdownTimespentgettingUsingdespitehealthGivesupactivitiesCravingToleranceWithdrawal
For patients with acute pain and OUD • DO treat acute pain on top of OUD
• PRN opioids work even if on bup • Split bup into TID or QID dosing to treat acute or
chronic pain • DO continue methadone or bup dosing before
and after surgery • DO use adjunctive medications, regional,
ketamine, etc This Toolkit Belongs To:
Case340-year-oldmanwithahistoryofOUDinrecoveryx2monthsonbuprenorphine16mgdailyisadmittedafteramotorvehicleaccidentandfoundtohavemultiplefracturesrequiringoperativerepair.● Whatdoyoudowithhisbuprenorphinebeforesurgery?Whatif
hewasonmethadone?● Whatdoyoudowithhisbuprenorphineafterthesurgeryto
managehispain?Whatifhewasonmethadone?
Whatcanyoudoatyourinstitution?Ø DispensenaloxoneforallpatientswhouseopioidsordrugsØ Ensurebuprenorphineandmethadoneareonformulary,continuedduring
hospitalization/surgery
Ø CreatehospitalordersetorguidelinefornewstartsØ PartnerwithstakeholdersØ Startprescribing!Ø Disseminateyourknowledgewithcolleagues
Objectives 1. Diagnoseandtreatopioidwithdrawalandopioid
usedisorder(OUD)witheithermethadoneorbuprenorphine
2. Identifyhowtolinkhospitalizedpatientstobuprenorphineormethadonetreatmentondischarge
3. NamethreeoptionsforOUDharmreduction
ReflectionsTake1minutetowritedown(ortweet):● Whatconceptortoolyouaretakingawayfromthis
workshop?
● WhatisoneaspectofOUDorharmreductionthatyoucanspeaktoprovidersatyourhomeinstitutionabouttoraiseawareness?
Thankyou!
Email me at [email protected]
Additional Resources: UCSF Substance use warmline: (855) 300-3595, 6am-5pm PT
SAMHSA, TIP 63: Medications for OUD www.ed-bridge.org